MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer

Summary: Activation of mitogenic signaling pathways is a common oncogenic driver of many solid tumors including lung cancer. Although activating mutations in the mitogen-activated protein kinase (MAPK) pathway are prevalent in non-small cell lung cancers, MAPK pathway activity, counterintuitively, i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rebecca Caeser, Christopher Hulton, Emily Costa, Vidushi Durani, Megan Little, Xiaoping Chen, Sam E. Tischfield, Marina Asher, Faruk Erdem Kombak, Shweta S. Chavan, Nisargbhai S. Shah, Metamia Ciampricotti, Elisa de Stanchina, John T. Poirier, Charles M. Rudin, Triparna Sen
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Biological sciences
Cell biology
Molecular biology
Science
Q
Acceso en línea:https://doaj.org/article/408084487e324b9abf64eba52e8ffc2a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/408084487e324b9abf64eba52e8ffc2a

Ejemplares similares